|
| Perspective From Industry Leaders |
|
|
| Generics Bulletin’s Top 50 Ranking For 2024 | VP Harris ‘Marches In’ To Presidential Campaign: Will Policy Change? |
|
This article compiles all of the data from Generics Bulletin’s 2024 ranking of the Top 50 firms across the generics... |
The shake up in the US presidential campaign line up could have implications for future drug pricing policies. VP... |
| Licensing & Collaboration Agreements |
|
|
| 2023’s Unpartnered Assets – Where Are They Now? | Deal Watch: BI Acquires Nerio For Novel Immune Checkpoint Inhibitor |
|
Last year, In Vivo spotlighted some of biopharma’s most highly valued yet unpartnered assets. Now it’s time... |
Featuring deals involving Novartis/Dren, Palvella/Pieris, Eyenovia/Senju, Addex/Johnson & Johnson... |
| Next Gen R&D |
|
|
| AI And Biosimilars: Untapped Area Full Of Potential – Or Hype? | Vanquishing Prostate Cancer Without Debilitating Side Effects – Francis Medical CEO On Water Vapor Ablation |
|
AI could help biosimilar developers with the development and manufacture of their products, but dependence on... |
Francis Medical believes it will be the first-line treatment of choice for prostate cancer patients and physicians... |
| Clinical Trials |
|
|
| Siga’s Mpox Pill Fails In Academic Trial | CMR Surgical Kick Off Pediatric Clinical Trial With Surgical Robot Versius |
|
The commercial implications of the miss are hard to call, but separate trials could offer hope. |
CMR Surgical has launched a multicenter pediatric clinical trial for its Versius surgical robot... |
|
|
|
Citeline Contact Poornachandra Tejasvi .K, 
|
IPA Contact Name: Hari Pranav K |